Clinical Research Directory
Browse clinical research sites, groups, and studies.
DigiDiab Pilot: Impact Study Hospital
Sponsor: Medical University of Graz
Summary
GlucoTab is an innovative workflow and decision support tool for standardised diabetes management by healthcare professionals which provides automated and personalised dosage recommendations for different insulin therapy regimens.
Official title: An Open, Multicentre, Prospective, Non-interventional Study of the CE-marked Medical Device GlucoTab, According to Intended Use Without Additional Invasive and Stressful Measures With a Matched Retrospective Control Group
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2025-04-01
Completion Date
2025-10-31
Last Updated
2025-08-01
Healthy Volunteers
No
Conditions
Interventions
GlucoTab
Insulin therapy will be started and adjusted according to the GlucoTab system with incorporated software algorithm. Insulin therapy prescription for the next 24 hours is suggested once daily by the GlucoTab system taking previous insulin doses, glucose readings, patient age, renal function and insulin sensitivity into account. The goal of the algorithm is to maintain fasting and premeal glucose concentrations between 100-140 mg/dl, (5.6 to 7.8 mmol/l).
Diabetes Treatment
Diabetes Standard Care
Locations (1)
Hospital Universitari Joan XXIII de Tarragona
Tarragona, Spain